Pharmacokinetics and pharmacodynamics of six epoetin alfa dosing regimens in anemic critically ill patients without acute blood loss. (отвара нови прозор)

Arroliga AC, Guntupalli KK, Beaver JS, Langholff W, Marino K, Kelly K

Извор‎: Crit Care Med 2009;37(4):1299-307.

Индекс‎: PubMed 19242343

DOI‎: 10.1097/CCM.0b013e31819cec94

https://www.ncbi.nlm.nih.gov/pubmed/19242343 (отвара нови прозор)

Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. (отвара нови прозор)

Ball AM, Winstead PS.

Извор‎: Pharmacotherapy 2008;28(11):1383-90.

Индекс‎: PubMed 18956998

DOI‎: 10.1592/phco.28.11.1383

https://www.ncbi.nlm.nih.gov/pubmed/18956998 (отвара нови прозор)

Reducing postburn injury anemia in a Jehovah's Witness patient. (отвара нови прозор)

Barsun A, Sen S, Palmieri TL, Greenhalgh DG

Извор‎: J Burn Care Res 2014;35(4):e258-61.

Индекс‎: PubMed 24121804

DOI‎: 10.1097/BCR.0b013e3182a366c5

https://www.ncbi.nlm.nih.gov/pubmed/24121804 (отвара нови прозор)

A US multicenter, retrospective, observational study of erythropoiesis-stimulating agent utilization in anemic, critically ill patients admitted to the intensive care unit. (отвара нови прозор)

Brophy GM, Sheehan V, Shapiro MJ, Lottenberg L, Scarlata D, Audhya P; ASSESS Study Group and Amgen Inc

Извор‎: Clin Ther 2008;30(12):2324-34.

Индекс‎: PubMed 19167591

DOI‎: 10.1016/j.clinthera.2008.12.024

https://www.ncbi.nlm.nih.gov/pubmed/19167591 (отвара нови прозор)

Severe acute anemia after liver transplantation in an elderly Jehovah's Witness treated with high-dose erythropoietin and ferric carboxymaltose: a case report. (отвара нови прозор)

Brunetta DM, Kaufman J, De Santis GC, Mesquita DF, Souza FN, Garcia JH.

Извор‎: Transplant Proc 2015;47(8):2548-51.

Индекс‎: PubMed 26518969

DOI‎: 10.1016/j.transproceed.2015.09.014

https://www.ncbi.nlm.nih.gov/pubmed/26518969 (отвара нови прозор)

Recombinant human erythropoietin in severe anaemia: issues of dosing and duration. (отвара нови прозор)

Charles A, Purtill M, Napolitano LM.

Извор‎: Anaesth Intensive Care 2006;34(6):793-6.

Индекс‎: PubMed 17183900

https://www.ncbi.nlm.nih.gov/pubmed/17183900 (отвара нови прозор)

Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. (отвара нови прозор)

Corwin HL, Gettinger A, Rodriguez RM, Pearl RG, Gubler KD, Enny C, Colton T, Corwin MJ.

Извор‎: Crit Care Med 1999;27(11):2346-50.

Индекс‎: PubMed 10579246

https://www.ncbi.nlm.nih.gov/pubmed/10579246 (отвара нови прозор)

Erythropoietin for critically ill trauma patients: a missed opportunity? (отвара нови прозор)

Corwin HL, Napolitano LM

Извор‎: J Trauma Acute Care Surg 2014;77(5):774-9.

Индекс‎: PubMed 25494432

DOI‎: 10.1097/TA.0000000000000442

https://www.ncbi.nlm.nih.gov/pubmed/25494432 (отвара нови прозор)

Postoperative management of severe acute anemia in a Jehovah's Witness. (отвара нови прозор)

de Araújo Azi LM, Lopes FM, Garcia LV

Извор‎: Transfusion 2014;54(4):1153-7.

Индекс‎: PubMed 24117834

DOI‎: 10.1111/trf.12424

https://www.ncbi.nlm.nih.gov/pubmed/24117834 (отвара нови прозор)

Restrictive transfusion in geriatric trauma patients. (отвара нови прозор)

DeLeon AN, Uecker JM, Stafford SV, Ali S, Clark A, Brown CV

Извор‎: Am Surg 2016;82(1):85-8.

Индекс‎: PubMed 26802863

https://www.ncbi.nlm.nih.gov/pubmed/26802863 (отвара нови прозор)

High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome. (отвара нови прозор)

Gabriel A, Kozek S, Chiari A, Fitzgerald R, Grabner C, Geissler K, Zimpfer M, Stockenhuber F, Bircher NG

Извор‎: J Trauma 1998;44(2):361-7.

Индекс‎: PubMed 9498512

DOI‎: 10.1097/00005373-199802000-00023

https://www.ncbi.nlm.nih.gov/pubmed/9498512 (отвара нови прозор)

Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]. (отвара нови прозор)

Georgopoulos D, Matamis D, Routsi C, Michalopoulos A, Maggina N, Dimopoulos G, Zakynthinos E, Nakos G, Thomopoulos G, Mandragos K, Maniatis A; Critical Care Clinical Trials Greek Group.

Извор‎: Crit Care 2005;9(5):R508-15.

Индекс‎: PubMed 16277712

DOI‎: 10.1186/cc3786

https://www.ncbi.nlm.nih.gov/pubmed/16277712 (отвара нови прозор)

Management of a Jehovah's Witness patient with sepsis and profuse bleeding after emergency coronary artery bypass graft surgery: rethinking the critical threshold of oxygen delivery. (отвара нови прозор)

Hong T, Shander A, Agarwal S, Castresana M.

Извор‎: A A Case Rep 2015;4(10):127-31.

Индекс‎: PubMed 25974416

DOI‎: 10.1213/XAA.0000000000000144

https://www.ncbi.nlm.nih.gov/pubmed/25974416 (отвара нови прозор)

Management strategies for perioperative anaemia in the severely burn-injured Jehovah's Witness patients who decline a blood transfusion: a systematic review with illustrative case reports. (отвара нови прозор)

Jung M, Harish V, Wijewardena A, Kerridge I, Gillies R

Извор‎: Burns. 2023 49(3):716-29. Epub 2022 Jul 18.

Индекс‎: PubMed 35941026

DOI‎: 10.1016/j.burns.2022.07.002

https://pubmed.ncbi.nlm.nih.gov/35941026/ (отвара нови прозор)

Long-term ECMO treatment in Jehovah's Witness patient without transfusions. (отвара нови прозор)

Lindholm J, Palmér K, Frenckner B.

Извор‎: Perfusion 2012;27(4):332-4.

Индекс‎: PubMed 22496111

DOI‎: 10.1177/0267659112444328

https://www.ncbi.nlm.nih.gov/pubmed/22496111 (отвара нови прозор)

Outcomes with the use of recombinant human erythropoietin in critically ill burn patients. (отвара нови прозор)

Lundy JB, Hetz K, Chung KK, Renz EM, White CE, King BT, Huzar T, Wolf SE, Blackbourne LH

Извор‎: Am Surg 2010;76(9):951-6.

Индекс‎: PubMed 20836341

https://www.ncbi.nlm.nih.gov/pubmed/20836341 (отвара нови прозор)

Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis. (отвара нови прозор)

Mesgarpour B, Heidinger BH, Schwameis M, Kienbacher C, Walsh C, Schmitz S, Herkner H.

Извор‎: Intensive Care Med 2013;39(11):1896-908.

Индекс‎: PubMed 23928897

DOI‎: 10.1007/s00134-013-3030-9

https://www.ncbi.nlm.nih.gov/pubmed/23928897 (отвара нови прозор)

Transfusion-free treatment strategies for acute anemia in critical care. (отвара нови прозор)

Morgan CA, Byul Sarah S, Forest CP.

Извор‎: JAAPA 2016;29(8):38-44.

Индекс‎: PubMed 27467297

DOI‎: 10.1097/01.JAA.0000488695.96294.33

https://www.ncbi.nlm.nih.gov/pubmed/27467297 (отвара нови прозор)

Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. (отвара нови прозор)

Napolitano LM, Fabian TC, Kelly KM, Bailey JA, Block EF, Langholff W, Enny C, Corwin HL.

Извор‎: J Trauma 2008;65(2):285-97.

Индекс‎: PubMed 18695463

DOI‎: 10.1097/TA.0b013e31817f2c6e

https://www.ncbi.nlm.nih.gov/pubmed/18695463 (отвара нови прозор)

Reticulocyte counts and their relation to hemoglobin levels in trauma patients. (отвара нови прозор)

Otterman ML, Nijboer JM, van der Horst IC, van Meurs M, ten Duis HJ, Nijsten MW

Извор‎: J Trauma 2009;67(1):121-4.

Индекс‎: PubMed 19590320

DOI‎: 10.1097/TA.0b013e318187a848

https://www.ncbi.nlm.nih.gov/pubmed/19590320 (отвара нови прозор)

Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. (отвара нови прозор)

Pieracci FM, Henderson P, Rodney JR, Holena DN, Genisca A, Ip I, Benkert S, Hydo LJ, Eachempati SR, Shou J, Barie PS.

Извор‎: Surg Infect (Larchmt) 2009;10(1):9-19.

Индекс‎: PubMed 19245362

DOI‎: 10.1089/sur.2008.043

https://www.ncbi.nlm.nih.gov/pubmed/19245362 (отвара нови прозор)

How do we treat life-threatening anemia in a Jehovah's Witness patient? (отвара нови прозор)

Posluszny JA Jr, Napolitano LM.

Извор‎: Transfusion 2014;54(12):3026-34.

Индекс‎: PubMed 25330835

DOI‎: 10.1111/trf.12888

https://www.ncbi.nlm.nih.gov/pubmed/25330835 (отвара нови прозор)

Recombinant human erythropoietin use in a critically ill Jehovah's Witness after cardiac surgery. (отвара нови прозор)

Price S, Pepper JR, Jaggar SI.

Извор‎: Anesth Analg 2005;101(2):325-7.

Индекс‎: PubMed 16037136

DOI‎: 10.1213/01.ANE.0000159158.70532.D0

https://www.ncbi.nlm.nih.gov/pubmed/16037136 (отвара нови прозор)

Successful rescue therapy for severe acute anemia: managing the critically ill Jehovah's Witness. (отвара нови прозор)

Rebel A, Beck A, Efron P, Bavry AA, Ang D.

Извор‎: Am Surg 2015;81(6):e263-5.

Индекс‎: PubMed 26031262

https://www.ncbi.nlm.nih.gov/pubmed/26031262 (отвара нови прозор)

Erythropoietin response is blunted in critically ill patients. (отвара нови прозор)

Rogiers P, Zhang H, Leeman M, Nagler J, Neels H, Mélot C, Vincent JL

Извор‎: Intensive Care Med 1997;23(2):159-62.

Индекс‎: PubMed 9069000

DOI‎: 10.1007/s001340050310

https://www.ncbi.nlm.nih.gov/pubmed/9069000 (отвара нови прозор)

Life-threatening postoperative blood loss in a Jehovah's Witness, treated with high-dose erythropoietin. (отвара нови прозор)

Schälte G, Janz H, Busse J, Jovanovic V, Rossaint R, Kuhlen R.

Извор‎: Br J Anaesth 2005;94(4):442-4.

Индекс‎: PubMed 15653706

DOI‎: 10.1093/bja/aei068

https://www.ncbi.nlm.nih.gov/pubmed/15653706 (отвара нови прозор)

Management of anemia in patients who decline blood transfusion. (отвара нови прозор)

Shander A, Goodnough LT

Извор‎: Am J Hematol 2018;93(9):1183-91.

Индекс‎: PubMed 30033541

DOI‎: 10.1002/ajh.25167

https://pubmed.ncbi.nlm.nih.gov/30033541/ (отвара нови прозор)

Erythropoiesis-stimulating agent administration and survival after severe traumatic brain injury: a prospective study. (отвара нови прозор)

Talving P, Lustenberger T, Inaba K, Lam L, Mohseni S, Chan L, Demetriades D.

Извор‎: Arch Surg 2012;147(3):251-5.

Индекс‎: PubMed 22430906

DOI‎: 10.1001/archsurg.2011.1838

https://www.ncbi.nlm.nih.gov/pubmed/22430906 (отвара нови прозор)

Intravenous iron following cardiac surgery does not increase the infection rate. (отвара нови прозор)

Torres S, Kuo YH, Morris K, Neibart R, Holtz JB, Davis JM.

Извор‎: Surg Infect (Larchmt) 2006;7(4):361-6.

Индекс‎: PubMed 16978079

DOI‎: 10.1089/sur.2006.7.361

https://www.ncbi.nlm.nih.gov/pubmed/16978079 (отвара нови прозор)

Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial. (отвара нови прозор)

Tsai TH, Lu CH, Wallace CG, Chang WN, Chen SF, Huang CR, Tsai NW, Lan MY, Sung PH, Liu CF, Yip HK

Извор‎: Crit Care 2015;19:49.

Индекс‎: PubMed 25888250

DOI‎: 10.1186/s13054-015-0761-8

https://www.ncbi.nlm.nih.gov/pubmed/25888250 (отвара нови прозор)

Pharmacotherapy for reducing RBC transfusion for patients in the ICU: a systematic review and network meta-analysis. (отвара нови прозор)

Yoshihiro S, Hongo T, Yamamoto M, Taito S, Kataoka Y

Извор‎: Crit Care Med 2024;52(4):618-25.

Индекс‎: PubMed 37962159

DOI‎: 10.1097/CCM.0000000000006114

https://pubmed.ncbi.nlm.nih.gov/37962159/ (отвара нови прозор)